Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2008 2
2009 6
2010 4
2011 2
2012 2
2013 6
2014 12
2015 7
2016 5
2017 10
2018 3
2019 3
2020 5
2021 2
2022 6
2023 4
2024 4
2025 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

78 results

Results by year

Filters applied: . Clear all
Page 1
Use of combination therapy is associated with improved LDL cholesterol management: 1-year follow-up results from the European observational SANTORINI study.
Ray KK, Aguiar C, Arca M, Connolly DL, Eriksson M, Ferrières J, Laufs U, Mostaza JM, Nanchen D, Bardet A, Lamparter M, Chhabra R, Soronen J, Rietzschel E, Strandberg T, Toplak H, Visseren FLJ, Catapano AL; SANTORINI Study Investigators. Ray KK, et al. Eur J Prev Cardiol. 2024 Nov 11;31(15):1792-1803. doi: 10.1093/eurjpc/zwae199. Eur J Prev Cardiol. 2024. PMID: 38861400
Efficacy of a Drug-Eluting Stent Versus Bare Metal Stents for Symptomatic Femoropopliteal Peripheral Artery Disease: Primary Results of the EMINENT Randomized Trial.
Gouëffic Y, Torsello G, Zeller T, Esposito G, Vermassen F, Hausegger KA, Tepe G, Thieme M, Gschwandtner M, Kahlberg A, Schindewolf M, Sapoval M, Diaz-Cartelle J, Stavroulakis K; EMINENT Investigators. Gouëffic Y, et al. Circulation. 2022 Nov 22;146(21):1564-1576. doi: 10.1161/CIRCULATIONAHA.122.059606. Epub 2022 Oct 18. Circulation. 2022. PMID: 36254728 Free article. Clinical Trial.
The TOPOS study.
Sebastian T, Barco S, Voci D, Lichtenberg M, Schlager O, Jalaie H, de Graaf R, Erbel C, Massmann A, Schindewolf M, Spirk D. Sebastian T, et al. Among authors: erbel c. Vasa. 2024 May;53(3):217-224. doi: 10.1024/0301-1526/a001118. Epub 2024 Mar 25. Vasa. 2024. PMID: 38525891
Drug-coated balloons in below-the-knee arteries.
Stoll F, Uslu R, Blessing E, Frey N, Katus HA, Erbel C, Heilmeier B, Müller OJ. Stoll F, et al. Among authors: erbel c. Vasa. 2022 Jul;51(4):256-262. doi: 10.1024/0301-1526/a001009. Epub 2022 May 23. Vasa. 2022. PMID: 35604329
Aspirin Plus Rivaroxaban Versus Rivaroxaban Alone for the Prevention of Venous Stent Thrombosis Among Patients With Post-Thrombotic Syndrome: The Multicenter, Multinational, Randomized, Open-Label ARIVA Trial.
Barco S, Jalaie H, Sebastian T, Wolf S, Fumagalli RM, Lichtenberg M, Zeller T, Erbel C, Schlager O, Kucher N. Barco S, et al. Among authors: erbel c. Circulation. 2025 Mar 25;151(12):835-846. doi: 10.1161/CIRCULATIONAHA.124.073050. Epub 2025 Jan 28. Circulation. 2025. PMID: 39874026 Free PMC article. Clinical Trial.
The Two Faces of Interleukin-17A in Atherosclerosis.
Akhavanpoor M, Akhavanpoor H, Gleissner CA, Wangler S, Doesch AO, Katus HA, Erbel C. Akhavanpoor M, et al. Among authors: erbel c. Curr Drug Targets. 2017;18(7):863-873. doi: 10.2174/1389450117666161229142155. Curr Drug Targets. 2017. PMID: 28034277 Review.
Prognostic Value of a Classification System for Iliofemoral Stenting in Patients with Chronic Venous Obstruction.
Jalaie H, Barbati ME, Piao L, Doganci S, Kucher N, Dumantepe M, Hartung O, Lichtenberg M, Black S, O'Sullivan G, Avgerinos ED, Davies AH, Razavi MK; International CVO Classification Study Group. Jalaie H, et al. Eur J Vasc Endovasc Surg. 2025 Feb;69(2):315-322. doi: 10.1016/j.ejvs.2024.10.002. Epub 2024 Oct 10. Eur J Vasc Endovasc Surg. 2025. PMID: 39393577 Free article.
78 results